Prion

Papers
(The median citation count of Prion is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Hypothesis: AA amyloidosis is a factor causing systemic complications after coronavirus disease18
Creutzfeldt-Jakob disease after COVID-19: infection-induced prion protein misfolding? A case report17
On the reactive states of astrocytes in prion diseases13
Development of molecular tools for diagnosis of Alzheimer’s disease that are based on detection of amyloidogenic proteins12
The role of microglia in prion diseases and possible therapeutic targets: a literature review9
Differential astrocyte and oligodendrocyte vulnerability in murine Creutzfeldt-Jakob disease6
Human prion disease surveillance in Spain, 1993-2018: an overview6
Decoding the role of coiled-coil motifs in human prion-like proteins6
Prion therapeutics: Lessons from the past6
A case of V180I genetic mutation Creutzfeldt Jakob disease (CJD) with delusional misidentification as an initial symptom5
The expanding scope of amyloid signalling5
Viruses and amyloids - a vicious liaison5
Genetic Creutzfeldt-Jakob disease shows fatal family insomnia phenotype4
Developing neuropalliative care for sporadic Creutzfeldt-Jakob Disease4
Prion 2022 Conference abstracts: pushing the boundaries4
18F-FP-CIT PET/CT in a case of probable sporadic Creutzfeldt-Jakob disease with parkinsonism as initial symptom3
Canine detection of chronic wasting disease (CWD) in laboratory and field settings3
Exploration of genetic factors resulting in abnormal disease in cattle experimentally challenged with bovine spongiform encephalopathy3
Copper coordination modulates prion conversion and infectivity in mammalian prion proteins3
Detection of two dissimilar chronic wasting disease isolates in two captive Rocky Mountain elk (Cervus canadensis) herds3
Upregulation of brain hepcidin in prion diseases3
STXBP1 forms amyloid-like aggregates in rat brain and demonstrates amyloid properties in bacterial expression system3
Preventive pharmacological treatment in subjects at risk for fatal familial insomnia: science and public engagement3
Characterization of the prion protein gene in axis deer (Axis axis) and implications for susceptibility to chronic wasting disease2
A Chinese patient with the clinical features of Parkinson’s disease contains a single copy of octarepeat deletion in PRNP case report2
Creutzfeldt–Jakob disease associated with a T188K homozygous mutation in the prion protein gene: a case report and review of the literature2
Creutzfeldt–Jakob disease in pregnancy: the use of modified RT-QuIC to determine infectivity in placental tissues2
Cellular prion protein distribution in the vomeronasal organ, parotid, and scent glands of white-tailed deer and mule deer2
Monomeric α-synuclein (αS) inhibits amyloidogenesis of human prion protein (hPrP) by forming a stable αS-hPrP hetero-dimer.2
The first non-prion pathogen identified: neurotropic influenza virus2
0.017850875854492